Beauty Farm Medical and Health Industry Inc. (HKG:2373)
20.34
+0.81 (4.15%)
At close: Mar 27, 2026
HKG:2373 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 317.56 | 228.46 | 215.66 | 103.11 | 193.48 |
Depreciation & Amortization | - | 377.24 | 327.72 | 293.81 | 272.89 |
Other Amortization | - | 5.34 | 4.02 | 3.43 | 2.3 |
Loss (Gain) From Sale of Assets | - | 7.08 | 1.01 | 0.91 | 2.64 |
Asset Writedown & Restructuring Costs | - | - | - | - | 0.03 |
Loss (Gain) From Sale of Investments | - | -20.68 | -23.85 | -20.7 | -23.41 |
Loss (Gain) on Equity Investments | - | - | 0.05 | - | - |
Stock-Based Compensation | - | -0.38 | 10.9 | 14.18 | 6.29 |
Provision & Write-off of Bad Debts | - | 3.91 | -0.05 | -0.03 | 1.31 |
Other Operating Activities | 681.53 | 53.44 | 55.19 | 33.77 | 40.63 |
Change in Accounts Receivable | - | 62.84 | -24.68 | -35.3 | -9.32 |
Change in Inventory | - | 56.3 | -47.95 | -46.36 | -31.73 |
Change in Accounts Payable | - | -9.74 | 45.76 | -26.33 | 59.23 |
Change in Unearned Revenue | - | 50.83 | 61.91 | 61.54 | 165.86 |
Change in Other Net Operating Assets | - | -18 | -0.17 | -0.03 | -10.25 |
Operating Cash Flow | 999.09 | 796.63 | 625.51 | 382 | 669.93 |
Operating Cash Flow Growth | 25.42% | 27.36% | 63.75% | -42.98% | -1.56% |
Capital Expenditures | - | -114.18 | -159.24 | -140.79 | -133.17 |
Sale of Property, Plant & Equipment | - | 2.69 | 0.6 | 0.22 | - |
Cash Acquisitions | - | -245.34 | -7.5 | -4.2 | -11.3 |
Divestitures | - | 0.08 | - | -2.13 | 3.66 |
Investment in Securities | - | -4.13 | -551.11 | 200.52 | -244.54 |
Other Investing Activities | -396.42 | 20.04 | 6.06 | - | - |
Investing Cash Flow | -396.42 | -340.85 | -711.19 | 53.63 | -385.35 |
Long-Term Debt Issued | - | 157.5 | - | - | - |
Long-Term Debt Repaid | - | -273.43 | -232.08 | -231.43 | -183.87 |
Net Debt Issued (Repaid) | - | -115.93 | -232.08 | -231.43 | -183.87 |
Issuance of Common Stock | - | - | 506.55 | 3.98 | 18.33 |
Repurchase of Common Stock | - | - | -12.01 | - | - |
Common Dividends Paid | - | -112.49 | -87 | -204.26 | -81.16 |
Other Financing Activities | 51.79 | 5.06 | -41.72 | -1.1 | -24.36 |
Financing Cash Flow | 51.79 | -223.36 | 133.74 | -432.82 | -271.07 |
Foreign Exchange Rate Adjustments | - | -0.53 | 12.09 | 4.03 | 0.23 |
Miscellaneous Cash Flow Adjustments | -0.75 | - | - | - | - |
Net Cash Flow | 653.71 | 231.88 | 60.16 | 6.84 | 13.75 |
Free Cash Flow | 999.09 | 682.44 | 466.27 | 241.21 | 536.76 |
Free Cash Flow Growth | 46.40% | 46.36% | 93.31% | -55.06% | -12.44% |
Free Cash Flow Margin | 33.30% | 26.53% | 21.74% | 14.75% | 30.14% |
Free Cash Flow Per Share | 4.31 | 2.97 | 2.03 | 1.21 | 2.69 |
Cash Interest Paid | - | 2.88 | - | - | 0.02 |
Cash Income Tax Paid | - | 42.46 | 28.19 | 27.09 | 45.93 |
Levered Free Cash Flow | 419.81 | 1,067 | 435.97 | 196.28 | 503.06 |
Unlevered Free Cash Flow | 439.92 | 1,084 | 451.48 | 211.73 | 518.2 |
Change in Working Capital | - | 142.23 | 34.87 | -46.48 | 173.78 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.